Schizophrenia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Schizophrenia stocks.

Schizophrenia Stocks Recent News

Date Stock Title
Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
Jul 3 LLY Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Jul 3 LLY 5 Things to Know Before the Stock Market Opens
Jul 3 LLY Eli Lilly Advances Alzheimer's Solutions With Kisunla Approval
Jul 3 LLY Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Jul 3 LLY Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Jul 2 LLY Boeing, Tesla stock reaction, small-cap portfolio: Market Domination
Jul 2 LLY Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease
Jul 2 LLY Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
Jul 2 LLY Alzheimer’s Disease Treatments: What to Know About New and Future Drugs
Jul 2 LLY Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2 LLY Eli Lilly Gets FDA Approval for Alzheimer's Disease Drug
Jul 2 LLY Biden, Sanders call for obesity drug makers to cut prices
Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal behavior, strange speech and a decreased ability to understand reality. Other symptoms include false beliefs, unclear or confused thinking, hearing voices that do not exist, reduced social engagement and emotional expression and lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood and in many cases never resolve.The causes of schizophrenia include environmental and genetic factors. Possible environmental factors include being raised in a city, cannabis use during adolescence, certain infections, the age of a person's parents, and poor nutrition during pregnancy. Genetic factors include a variety of common and rare genetic variants. Diagnosis is based on observed behavior, the person's reported experiences and reports of others familiar with the person. During diagnosis, a person's culture must also be taken into account. As of 2013, there is no objective test. Schizophrenia does not imply a "split personality" or dissociative identity disorder, conditions with which it is often confused in public perception.The mainstay of treatment is antipsychotic medication, along with counselling, job training and social rehabilitation. It is unclear whether typical or atypical antipsychotics are better. In those who do not improve with other antipsychotics, clozapine may be tried. In more serious situations where there is risk to self or others, involuntary hospitalization may be necessary, although hospital stays are now shorter and less frequent than they once were.About 0.3% to 0.7% of people are affected by schizophrenia during their lifetimes. In 2013, there were an estimated 23.6 million cases globally. Males are more often affected and on average experience more severe symptoms. About 20% of people eventually do well, and a few recover completely; about 50% have lifelong impairment. Social problems, such as long-term unemployment, poverty and homelessness, are common. The average life expectancy of people with the disorder is 10–25 years less than that of the general population. This is the result of increased physical health problems and a higher suicide rate (about 5%). In 2015, an estimated 17,000 people worldwide died from behavior related to, or caused by, schizophrenia.

Browse All Tags